ProBeam Proton Therapy System
Device Oncology
PDI 00858991006019
General payments
$2,496,148
Research payments
$872,114
Through program year 2025, $2,496,148 in general payments and $872,114 in research payments were reported against ProBeam Proton Therapy System (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $217,529 | 4 |
| 2025 | Research | $294,186 | 6 |
| 2024 | General | $1,139,343 | 8 |
| 2024 | Research | $78,887 | 3 |
| 2023 | General | $504,220 | 13 |
| 2023 | Research | $234,194 | 8 |
| 2022 | General | $315,427 | 64 |
| 2022 | Research | $31,975 | 1 |
| 2021 | General | $319,628 | 21 |
| 2021 | Research | $232,871 | 6 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
110 general · 24 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.